Louis Moore Bacon's WST Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 95,000 shares of West Pharmaceutical Services, Inc. (WST) worth $24.92 M, representing 0.34% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in WST for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 95,000 shares. Largest reduction occurred in Q1 2025, reducing 63,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +5,000 | New Buy | 5,000 | $346.47 |
| Q2 2023 | -5,000 | Sold Out | 0 | $0.00 |
| Q1 2024 | +65,000 | New Buy | 65,000 | $395.71 |
| Q2 2024 | +15,000 | Add 23.08% | 80,000 | $329.39 |
| Q3 2024 | -15,000 | Reduce 18.75% | 65,000 | $300.16 |
| Q4 2024 | -2,000 | Reduce 3.08% | 63,000 | $327.56 |
| Q1 2025 | -63,000 | Sold Out | 0 | $0.00 |
| Q3 2025 | +95,000 | New Buy | 95,000 | $262.33 |
Louis Moore Bacon's West Pharmaceutical Services Investment FAQs
Louis Moore Bacon first purchased West Pharmaceutical Services, Inc. (WST) in Q1 2023, acquiring 5,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held West Pharmaceutical Services, Inc. (WST) for 8 quarters since Q1 2023.
Louis Moore Bacon's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q3 2025, adding 95,000 shares worth $24.92 M.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 95,000 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $24.92 M.
As of the Q3 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.34% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in West Pharmaceutical Services, Inc. (WST) was 95,000 shares, as reported at the end of Q3 2025.